1. Home
  2. MTH vs GPCR Comparison

MTH vs GPCR Comparison

Compare MTH & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meritage Homes Corporation

MTH

Meritage Homes Corporation

HOLD

Current Price

$59.35

Market Cap

4.4B

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

BUY

Current Price

$21.92

Market Cap

3.8B

Sector

N/A

ML Signal

BUY

Company Overview

Basic Information
Metric
MTH
GPCR
Founded
1985
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.8B
IPO Year
1997
2023

Fundamental Metrics

Financial Performance
Metric
MTH
GPCR
Price
$59.35
$21.92
Analyst Decision
Buy
Strong Buy
Analyst Count
9
16
Target Price
$75.22
★ $105.78
AVG Volume (30 Days)
846.7K
★ 1.2M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 3.19%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.18
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.53
N/A
P/E Ratio
$27.66
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$56.66
$20.73
52 Week High
$85.38
$94.90

Technical Indicators

Market Signals
Indicator
MTH
GPCR
Relative Strength Index (RSI) 41.61 22.84
Support Level $57.94 N/A
Resistance Level $71.07 $57.15
Average True Range (ATR) 1.70 1.43
MACD 0.14 0.17
Stochastic Oscillator 34.71 14.61

Price Performance

Historical Comparison
MTH
GPCR

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising twelve states: Arizona, California, Colorado, Utah, Tennessee, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, and South Carolina. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the Homebuilding segment.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: